2022
DOI: 10.1007/s00417-022-05837-w
|View full text |Cite
|
Sign up to set email alerts
|

Studies on the interactions of retinal dopamine with choroidal thickness in the chicken

Abstract: Purpose Recently, an increasing number of studies relied on the assumption that visually induced changes in choroidal thickness can serve as a proxy to predict future axial eye growth. The retinal signals controlling choroidal thickness are, however, not well defined. We have studied the potential roles of dopamine, released from the retina, in the choroidal response in the chicken. Methods Changes in retinal dopamine release and choroidal thickness change… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 65 publications
(120 reference statements)
0
5
0
Order By: Relevance
“…We can therefore only speculate if the effect is a direct receptor-mediated effect in this tissue, or an indirect effect. An indirect effect of baclofen mediated solely by changes in dopamine metabolism can be excluded, since it was shown that retinal dopamine and DOPAC levels are positively correlated with ChT in the open eyes of chickens [ 57 ] but not in ametropic eyes, as indicated by lower retinal dopamine metabolism and higher ChT in LIH eyes.…”
Section: Discussionmentioning
confidence: 99%
“…We can therefore only speculate if the effect is a direct receptor-mediated effect in this tissue, or an indirect effect. An indirect effect of baclofen mediated solely by changes in dopamine metabolism can be excluded, since it was shown that retinal dopamine and DOPAC levels are positively correlated with ChT in the open eyes of chickens [ 57 ] but not in ametropic eyes, as indicated by lower retinal dopamine metabolism and higher ChT in LIH eyes.…”
Section: Discussionmentioning
confidence: 99%
“…Choroidal blood flow and CT are regulated by the autonomic nervous system (sympathetic nervous stimulation causes a substantial reduction in choroidal blood flow and CT [31,[63][64][65][66], and the parasympathetic input to the choroid has a vasodilation effect and serves to increase choroidal blood flow and CT [31,32,67,68]). The intrinsic rhythm of the choroid is also influenced by the autonomic nervous system (the choroid possesses a network of intrinsic choroidal neurons that lie in the choroidal stroma [12,32,69], and these intrinsic choroidal neurons appear to receive both sympathetic and parasympathetic input, suggesting they are controlled by the autonomic nervous system [70,71]). In addition, the choroid can release certain autonomic neurotransmitters (eg, vasoactive intestinal peptide, nitric oxide) [12,24,31,71] and change the permeability of the choroid, making the growth factor released by the choroid more easily arrive at the sclera, and further remodel the scleral extracellular matrix [11,61,72,73].…”
Section: Discussionmentioning
confidence: 99%
“…The intrinsic rhythm of the choroid is also influenced by the autonomic nervous system (the choroid possesses a network of intrinsic choroidal neurons that lie in the choroidal stroma [ 12 , 32 , 69 ], and these intrinsic choroidal neurons appear to receive both sympathetic and parasympathetic input, suggesting they are controlled by the autonomic nervous system [ 70 , 71 ]). In addition, the choroid can release certain autonomic neurotransmitters (eg, vasoactive intestinal peptide, nitric oxide) [ 12 , 24 , 31 , 71 ] and change the permeability of the choroid, making the growth factor released by the choroid more easily arrive at the sclera, and further remodel the scleral extracellular matrix [ 11 , 61 , 72 , 73 ]. Thus, changes in autonomic nervous system activity in myopia may accelerate the progression of axial elongation and myopia by regulating the choroid and sclera.…”
Section: Discussionmentioning
confidence: 99%
“…As a result, they may modulate changes in ChT by causing fluid efflux within the choroid, leading to its thinning. 33,35,36 Atropine (also an anti-muscarinic agent) has been shown to increase ChT, potentially through nitric oxide 37 or dopamine 38 pathways. Cyclopentolate may affect the same pharmacological mechanisms, but analysis of the short-term ChT changes within the atropine and placebo groups showed that post-cyclopentolate choroidal thinning did not differ significantly between the atropine and placebo groups.…”
Section: Subfoveal Region Subfovealmentioning
confidence: 99%